Patent Assignment
Reel/Frame 032316/0591
Assignment of Assignor's Interest
Recorded: 2014-02-27
Pages: 3
Assignor
HERLEV HOSPITAL
Executed: 2013-11-08
Assignee
NANOSTRING TECHNOLOGIES, INC.
530 FAIRVIEW AVENUE NORTH, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Methods of Treating Breast Cancer with Gemcitabine Therapy
Application:
13/930,249 →
Publication:
US 2014/0037620
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 29, 2013
From: FERREE, SEAN M.; COWENS, J. WAYNE
To: NANOSTRING TECHNOLOGIES, INC.
Reel/Frame 031109/0428 →
Assignment of Assignor's Interest
Sep 5, 2013
From: NIELSEN, TORSTEN O.
To: BRITISH COLUMBIA CANCER AGENCY BRANCH
Reel/Frame 031142/0746 →
Assignment of Assignor's Interest
Feb 25, 2014
From: EJLERTSEN, BENT
To: RIGSHOSPITALET
Reel/Frame 032295/0379 →
Assignment of Assignor's Interest
Feb 25, 2014
From: JORGENSEN, CHARLOTTE LEVIN TYKJAER
To: HERLEV HOSPITAL
Reel/Frame 032295/0393 →
Assignment of Assignor's Interest
Feb 27, 2014
From: RIGSHOSPITALET
To: NANOSTRING TECHNOLOGIES, INC.
Reel/Frame 032316/0576 →
Security Interest
Apr 18, 2014
From: NANOSTRING TECHNOLOGIES, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 032707/0178 →
Termination and Release of Security Interest in Patents
Mar 10, 2020
From: CRG SERVICING LLC
To: NANOSTRING TECHNOLOGIES, INC.
Reel/Frame 052135/0989 →